Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health

Blogs Comment On Ryan-DeLauro Bill, Sex Education Funding, State Reproductive Health Legislation

The following summarizes selected women"s health-related blog entries.~ "A Taxing Problem," Jessica Arons, Huffington Post blogs: The five Democrats who last week sent a letter to House Speaker Nancy Pelosi (D-Calif.) "suggesting a "common ground" solution to the abortion "roadblock" in health care reform" should be "applauded" for keeping the debate"s focus on covering the uninsured and "for being unwilling to sacrifice health care reform on the altar of abortion politics," writes Jessica Arons, director of the Women"s Health & Rights Program at the Center for American Progress. Arons adds that while the proposal, led by antiabortion-rights Rep. Tim Ryan (D-Ohio), "is in welcome contrast to the stonewalling and ultimatums coming from Rep. Bart Stupak (D-Mich.) and his allies," it is "based on a misguided and attenuated definition of government spending, and it conflicts with what Americans want and expect from health care reform." She continues that the "suggestion that a health plan might offer abortion coverage, and it might be used by someone, who might have paid a lower premium than someone else, because the government might have helped pay their premium is a horrible reason for Congress to carve out an explicit exception to a bill that is otherwise entirely silent on coverage options." Taxpayers "do not have the right to specify how their tax money should be spent," she writes, adding, "I understand why people would want to withhold their taxes from purposes they oppose, but our system does not -- nor should it -- work that way" (Arons, Huffington Post blogs, 7/30).~ "The Breakup of the Pro-Life Movement," Cristina Page, Birth Control Watch: Rep. Ryan is "in many ways a typical pro-life American" who opposes abortion rights and, "like most pro-life Americans, ... supports every effort to prevent the need for it," including contraception, Page writes. However, because of his support for contraception and sponsorship of the "Preventing Unintended Pregnancies, Reducing the Need for Abortion and Supporting Parents Act," Ryan was "banished" from the board of Democrats for Life of America, Page writes, adding that antiabortion-rights publications have "taken to qualifying his pro-life status as "allegedly" pro-life or referring to him as someone "who claims to be" pro-life." The bill, also known as the Ryan-DeLauro bill, would increase funding for contraception, and support comprehensive sex education and services for women who choose to carry unintended pregnancies to term, Page writes. She notes that the bill is supported by "many prominent pro-life individuals" and groups that support abortion rights, though "[n]ot one leading pro-life group signed onto the bill." Page writes, "Pro-life Americans favor expanding access to contraception because of the undeniable pro-life results," adding, "Unintended pregnancy is the root cause of abortion. We know when used properly, contraception works." It is "time for the disagreement over contraception to be addressed by the pro-life community at large," she writes, adding, "We will have no chance of making a real impact on unintended pregnancy and abortion rates without dramatic, informed strategies on prevention" (Page, Birth Control Watch, 7/28).~ "Senate Subcommittee: Ab-Only Out, Syringe Ban Still In; Advocates Hope for Further Changes in Conference Committee," Jodi Jacobson, RH Reality Check: The spending bill approved yesterday by the Senate Appropriations Committee "zeroes out funding" for the Community-Based Abstinence Education program, which has "for years [been] the main of support for now-discredited abstinence-only programs," Jacobson writes. The "elimination of these funds parallels similar action in the House, ... so unless amendments are proposed, accepted and passed during either the full committee vote or on the Senate floor, this bill spells "the end of abstinence-only programs as we know them," said one advocate, "at least for this year,"" Jacobson writes. The Senate version of the bill allocate

Experimental Drug Five Times More Effective Against MDR-TB Than Conventional Therapy

A Johnson & Johnson-run study found that its experimental drug TMC207 could make conventional tuberculosis treatment five times more effective against multi-drug resistant TB (MDR-TB) because it cleared traces of the TB bacteria in the sputum of 48 percent of study volunteers after eight weeks, Reuters reports (Emery, Reuters, 6/3). The results were published on Wednesday in the New England Journal of Medicine.